Spatial Genomics and Transcriptomics Market, 2030
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
Global Spatial Genomics and Transcriptomics Market to Reach $2,173.0 Million by 2030, progressing at a CAGR of 23.20%.
The market is driven by certain factors, which include the increasing prevalence of various types of genetic disorders, such as cancer, neurological disorder, and rare diseases, inciting the development of high-resolution multiplex assays and instruments, technological advancements in sequencing technologies, and significant research funding in the field of spatial-based technology for executing R&D exercises.
The market is favored by the development of spatial profiling-based solutions for visualization and analysis of tissue microenvironment, tumor biology, and tissue biomarker. The gradual increase in the prevalence of neurological disorders and rare diseases globally has furthered the spatial genomics and transcripto
Message :
Required fields
Data in Twenty-One Poster and Oral Presentations Highlight use of GeoMx Digital Spatial Profiler and the Spatial Molecular Imager Platform for Discovery and Translational Applications
NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of a Technology Access Program (TAP) for the Spatial Molecular Imager. Under the program, a customer can submit tissue samples to NanoString to be analyzed using the 1000-plex RNA panel and receive a complete data package. Researchers interested in participating in NanoString’s Technology Access Program should contact the company at TAP@nanostring.com.
Key Companies Profiled
$3,188.9 Million
Healthcare experts have found the single-cell multi-omics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 21.16% during the forecast period, 2020-2025. The market is driven by the need for the development of an advanced solution based on single-cell technology for clinical research in various applications such as cancer, rare disease, cell biology, and synthetic biology, among others.
The market is favored by the development of single-cell technology-based solutions for visualization and analysis of cell heterogeneity, tumor microenvironment, and antibody development. The gradual increase in the prevalence of oncology and rare diseases globally has furthered the single-cell multi-omics market.
NanoString to Host the 3rd Annual “Spatial Genomics Summit,” February 23-24, 2021
Share Article
Don’t miss the opportunity to learn more about the accelerating research discoveries in Spatial Genomics with advancements arriving every day.
NanoString to Host the 3rd Annual “Spatial Genomics Summit,” February 23-24, 2021. SEATTLE (PRWEB) February 18, 2021
NanoString Technologies to hold the 3rd Annual “Spatial Genomics Summit” virtually on February 23, 2021 (February 24 – Asia-Pacific), on the LabRoots platform. It is a chance to learn about exciting, dynamic, and rapidly evolving spatial technology. A keynote panel discussion on Research in Spatial Genomics Era, with leaders from academia and industry An exciting selection of Rapid Application Presentations (RAP)
NanoString to Host the 3rd Annual Spatial Genomics Summit, February 23-24, 2021 thetelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thetelegraph.com Daily Mail and Mail on Sunday newspapers.